Development and validation of a specific stability indicating high performance liquid chromatographic method for valsartan

Journal of Young Pharmacists

Volumn 2, Issue 2, 2010, Pages 183-189

  Rao, K S ^a   Jena, N ^a   Rao, M E B ^a  

^a ROLAND INSTITUTE OF PHARMACEUTICAL SCIENCES   (India)

Author keywords

Assay; stress studies; validation; valsartan

Indexed keywords

ACETONITRILE; PHOSPHORIC ACID; VALSARTAN;

ANALYTIC METHOD; ARTICLE; DRUG DEGRADATION; DRUG DOSAGE FORM; DRUG STABILITY; PH; PRIORITY JOURNAL; QUALITY CONTROL; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; TABLET; TEMPERATURE STRESS; VALIDATION PROCESS;

EID: 78049392172     PISSN: 09751483     EISSN: 09751505     Source Type: Journal    
DOI: 10.4103/0975-1483.63166     Document Type: Article

References (11)

1. Bakshi M, Singh B, Singh A, Singh S. ICH guidance in practice: Stress degradation studies on ornidazole and development of a validated stability-indicating assay. J Pharm Biomed Anal 2001;26:891-7.
2. ICH Topic Q1A (R2): stability testing of new drug substances and products, in: Proceedings of the International Conference on Harmonisation. London: EMEA; 2003.
3. Macek J, Klima J, Ptacek P. Rapid determination of valsartan in human plasma by protein precipitation and high-performance liquid chromatography. J Chromatogr B Analyt Technol Biomed Life Sci 2006;832:169-72.
4. Daneshtalab N, Lewanczuk RZ, Jamali F. High-performance liquid chromatographic analysis of angiotensin II receptor antagonist valsartan using a liquid extraction method. J Chromatogr B Analyt Technol Biomed Life Sci 2002;766:345-9.
5. Koseki N, Kawashita H, Hara H, Niina M, Tanaka M, Kawai R, et al. Development and validation of a method for quantitative determination of valsartan in human plasma by liquid chromatography-tandem mass spectrometry. J Pharm Biomed Anal 2007;43:1769-74.
6. Gonzalez L, Lopez JA, Alonso RM, Jimenez RM. Fast screening method for the determination of angiotensin ii receptor antagonists in human plasma by high-performance liquid chromatography with fluorimetric detection. J Chromatogr A 2002;949:49-60.
7. Francotte E, Davatz A, Richert P. Development and validation of chiral high-performance liquid chromatographic methods for the quantitation of valsartan and of the tosylate of valinebenzyl ester. J Chromatogr B Biomed Appl 1996;686:77-83.
8. Senthamil SP, Veeran GK, Mandal U, Solomon WD, Pal TK. Simultaneous determination of fixed dose combination of nebivolol and valsartan in human plasma by liquid chromatographic-tandem mass spectrometry and its application to pharmacokinetic study. J Chromatogr B Analyt Technol Biomed Life Sci 2007;858:143-50.
9. Eda S, Sadi A, Nilgun GG, Sibel O, Zuhre S. Simultaneous determination of valsartan and hydrochlorothiazide in tablets by first-derivative ultraviolet spectrophotometry and lc. J Pharm Biomed Anal 2001;25:1009-13.
10. Tatar S, Saglk S. Comparison of UV-and second derivative- spectrophotometric and LC methods for the determination of Valsartan in pharmaceutical formulation. J Pharm Biomed Anal 2002;30:371-5.
11. Agrahari V, Kabra V, Gupta S, Nema RK, Nagar M, Karthikeyan C, et al. Determination of Inherent Stability of Valsartan by Stress Degradation and Its Validation by HPLC. Int J Pharm Clin Res 2009;1:77-81.S